Congenital Haemorrhagic Condition Similar but Not Identical to Factor X Deficiency
- 1 May 1970
- journal article
- case report
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 7 (2) , 91-99
- https://doi.org/10.1111/j.1600-0609.1970.tb01874.x
Abstract
A 23‐year‐old white male with a bleeding tendency since early childhood presented a congenital coagulation defect similar but not identical to factor X deficiency. A first and second stage defect were demonstrated, characterized by a prolonged prothrombin time, prolonged partial thromboplastin time, abnormal thromboplastin generation, abnormal prothrombin consumption. The Stypven clotting time was slightly prolonged on fresh plasma but was normal on frozen plasma. Factors I, II, V, VIII, IX, XI, and XII were all within normal limits; factor VII was at the lower limits of normally or slightly decreased.Mr. Stuart's plasma failed to correct the defect of the patients plasma; however, a known factor VII deficient plasma was able to correct the abnormality. Factor X levels showed low (3–13%) only when assayed using tissue whole thromboplastin or tissue partial thromboplastin; the factor X assay using a Stypven‐cephalin mixture yielded normal or near normal values. The factor II + factor X level using a Stypven‐cephalin mixture appeared normal also.The significance of the findings is discussed. The results are tentatively interpreted as being due to an abnormal factor X rather than to a real deficiency.This publication has 19 references indexed in Scilit:
- THE INHERITANCE OF STUART DISEASEThe Lancet Healthy Longevity, 1965
- The Specific Assay of Prower-Stuart Factor and Factor VIIActa Haematologica, 1961
- The Stuart-Prower Factor: Utilization of Clotting Factors obtained by Starch-Block Electrophoresis for Genetic EvaluationBritish Journal of Haematology, 1961
- Familiärer Faktor X-MangelKlinische Wochenschrift, 1958
- A Rapid Screening Test for Disorders of Thromboplastin GenerationBritish Journal of Haematology, 1957
- Stuart Clotting Defect. I. Segregation of an Hereditary Hemorrhagic State from the Heterogeneous Group Heretofore Called “Stable Factor” (SPCA, Proconvertin, Factor VII) DeficiencyJournal of Clinical Investigation, 1957
- Stuart Clotting Defect. II. Genetic Aspects of a `New' Hemorrhagic StateJournal of Clinical Investigation, 1957
- A ‘New’ Coagulation DefectBritish Journal of Haematology, 1956
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951
- A CLINICAL STUDY OF THE COAGULATION TIME OF BLOODThe Lancet Healthy Longevity, 1913